Managing GERD in Children with Asthma with H2 receptor antagonists (H2RAs): Indian Paediatricians' Perspectives Dr. Garima Soni5 Dec 2025 12:30 PM ISTGastroesophageal reflux disease (GERD) symptoms extend beyond typical esophageal symptoms such as heartburn and regurgitation, with asthma emerging...
FDA Clears New, Safer Formulation of Ranitidine After Full Safety Evaluation Dr. Kamal Kant Kohli1 Dec 2025 10:30 AM ISTThe U.S. Food and Drug Administration has approved reformulated ranitidine tablets, marking the return of this important acid-reducing medication to...
Chronic Cough Reported in Patients Using GLP-1 Drugs, Study Finds Medha Baranwal28 Nov 2025 10:30 AM ISTUSA: A new multicenter US cohort study has identified a potential link between the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs)—widely...
Alembic Pharma bags USFDA nod for erosive esophagitis drug Dexlansoprazole Delayed Release Ruchika Sharma13 Nov 2025 1:31 PM ISTVadodara: Pharma firm Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug...
H2 receptor antagonists (H2RAs) in Gastrointestinal Care of Neonates and Infants: Indian Paediatricians' Perspectives Dr. Garima Soni8 Nov 2025 11:50 AM ISTGastrointestinal (GI) conditions are common in neonates and infants. These may include Gastroesophageal Reflux (GER), Gastroesophageal Reflux...
GERD Linked to Higher Risk of Developing Alcohol Use Disorder: Study Jacinthlyn Sylvia24 Oct 2025 8:54 AM ISTA new study published in the Journal of the American Board of Family Medicine found that patients with gastroesophageal reflux disease (GERD) have an...
CPAP Therapy Eases Acid Reflux Symptoms in Patients With Sleep Apnea, Indian Study Reports Medha Baranwal7 Sept 2025 8:30 PM ISTIndia: A new prospective cohort study from India has revealed that consistent use of continuous positive airway pressure (CPAP) therapy not only...
Risk for GERD higher with GLP-1 RA use compared to SGLT-2 inhibitor use: Study Dr. Kamal Kant Kohli19 July 2025 8:30 AM ISTA population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared with...
Tegoprazan Shows Superior Efficacy and Safety in Treating Esophageal Conditions in Phase 3 trial Dr. Kamal Kant Kohli9 May 2025 8:45 PM ISTIn a phase 3 trial Tegoprazan Shows Superior Efficacy and Safety in Treating Esophageal Conditions. It was found that Tegoprazan acted faster and was...
Laparoscopic "Tunnel" Approach Enhances Surgical Outcomes of hiatus hernia with GERD: Study Jacinthlyn Sylvia30 April 2025 8:30 PM ISTA new study published in the journal of BMC Surgery showed that the laparoscopic "tunnel" approach significantly reduces the risk of vagus nerve...
Alembic Pharma bags USFDA final approval for Pantoprazole Sodium for Injection for GERD Ruchika Sharma2 April 2025 2:48 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug Administration (USFDA)...
Potassium-Competitive Acid Blockers: AGA Review Offers Insights on Optimal Use in GI Disorders Medha Baranwal27 Jan 2025 8:30 PM ISTUSA: The American Gastroenterological Association (AGA) has released a Clinical Practice Update (CPU) aimed at integrating potassium-competitive acid...
